Elevated drug saliva levels suggest a "depot-like" effect in subjects treated with sublingual buprenorphine

NIDA Res Monogr. 1990:105:569.
No abstract available

MeSH terms

  • Administration, Sublingual
  • Buprenorphine / administration & dosage
  • Buprenorphine / pharmacokinetics*
  • Delayed-Action Preparations
  • Humans
  • Saliva / chemistry*

Substances

  • Delayed-Action Preparations
  • Buprenorphine